Clinical study on Yupingfengguizhi solution assisted hormone Withdrawal and reduction in rheumatoid arthritis (Wind-Cold-Dampness Arthralgia Syndrome)

Yunnan Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. According to the ACR rheumatoid arthritis diagnostic criteria of 1987 and TCM diagnostic criteria of wind cold dampness syndrome;
•2. Patients with RA disease activity whose DAS28 score is greater than 2.6;
•3. Patients who had taken glucocorticoids (prednisone acetate tablets >= 20mg/d or equivalent dose if DAS28 score >= 5.1; Prednisone Acetate Tablets >= 10mg/d or equivalent dose if DAS28 score < 5.1);
•4. Aged from 18 to 65 years, male or female;
•5. Those who voluntarily participate in the trial and agree to enter the clinical study and sign the informed consent.

•1. There was a history of severe respiratory (including pulmonary interstitial fibrosis), blood circulation disorder, digestive, endocrine, urinary system diseases and malignant tumor before the trial;
•2. Patients with bleeding tendency, active gastrointestinal disease and recent history of surgery;
•3. There was infection that could not be controlled by antibiotics, and there was a history of severe infection or opportunistic infection 2 months before the trial;
•4. Biological agents have been used in recent one month;
•5. Pregnant and lactating women;
•6. Patients participating in other clinical trials;
•7. Allergic constitution (allergic to traditional Chinese medicine, hormone and other experimental drugs);
•8. Mental patients;
•9. Suspected or true history of alcohol or drug abuse, or other diseases that reduce or complicate the possibility of enrollment, such as frequent changes in working environment, are likely to cause loss of follow-up.

发起方

Yunnan Traditional Chinese Medicine Hospital